Biotechnology Stocks II Performance Guide: Arbutus Biopharma Corporation (ABUS)
ABUS has no dividends.
Table and Chart of ABUS Performance
See what a $1,000 investment in ABUS is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| ABUS Returns | |
|---|---|
| Start Date | Sep-30-2015 |
| Start Price | $6.09 |
| End Date | Jul-26-2024 |
| End Price | $3.90 |
| # Prices | 107 |
| Min Date | Mar-31-2020 |
| Min Price | $1.01 |
| Max Date | Jul-31-2018 |
| Max Price | $11.10 |
| Total Return | -35.96% |
| Annualized Return | -4.88% |
| Current Value of $1,000 Purchase | $640 |
| Number Returns | 5,671 |
| Average Return | -6.24% |
| Number Profitable Returns | 1,898 |
| Percent Profitable Returns | 33.47% |
| Number Unprofitable Returns | 3,773 |
| Percent Unprofitable Returns | 66.53% |
| Profitable to Unprofitable Returns Ratio | 0.50 |
| ABUS Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $735,053,000 |
| Beta | 1.957 | Price to Sales | 28.90 |
| Earnings per Share | $-0.4400 |
| PE Ratio | None |
| PE to Growth Ratio | 0 |
| Price to Book | 4.946 |
| PRICE DATA | |
| 52 Week High | $3.98 |
| 52 Week Low | $1.69 |
| Analyst Target Price | $4.4 |
| 50-Day Moving Average | $3.306 |
| 200-Day Moving Average | $2.624 |
| FINANCIAL DATA | |
| Revenue per Share | $0.077 |
| Revenue | $12,986,000 |
| Profit Margin | 0% |
| Return on Equity | -57.5% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
ABUS Compare Returns with S&P 500
ABUS Trendline Chart
ABUS Moving Average Chart
ABUS Stock Return Map - See Patterns of Gains and Losses
ABUS Stock Returns/Purchase Dates